Email  |  BV_FTP  |  OA

Hotline:+86 27 8798 8585  CN   |   EN

CN   |   EN

Current location:Home >> Latest News >> Company News

BravoBio was Invited to “China International Vaccine Innovation Summit (HVIS) 2022”

Author:博沃管理员    Release time:2022-08-11 15:41:00

On August 8-9th, 2022, with the theme of “Let some people get future-ready first”, “China International Vaccine Innovation Summit (HVIS) 2022” was held in Beijing, China. KOLs and companies from vaccine industries were invited to the Summit, and together redefined the new era of vaccine. BravoBio, as a pioneer company dedicated in innovative human vaccines, was invited to the Summit, and Mr. Qin Mian, Manager of COVID-19 Project from BravoBio, gave a keynote speech on "Key points on development of pan-Sarbecovirus vaccine".

图片

The Summit was divided into three parallel venues for Human Vaccines, Veterinary Vaccines and Frontiers of Vaccines. In his speech at the venue of Human Vaccines, Mr. Qin said, “The repeated infection of novel coronavirus will continuously increase our health risk and disease burden. Under this circumstance, it is a difficult but significant task for us to develop a broad-spectrum coronavirus vaccine“. During the round table discussion, KOLs from vaccine industries said, “To get our vaccine manufacturers ready to enter into international markets, it’s very important to develop vaccines based on the market of target countries from the very beginning of vaccine design.”